The global pre-filled syringes market was valued at $9.8bn in 2018. This market is estimated to grow at a CAGR of 12.9% in the first half of the forecast period. In 2018, the glass pre-filled syringes submarket held 53% of the global pre-filled syringes.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new report, you will find 274-page report and you will receive 101 tables and 86 figures – all unavailable elsewhere.
The 274-page report provides clear detailed insight into the global pre-filled syringes market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Pre-Filled Syringes market forecasts from 2019-2029
• Pre-Filled Syringes submarket forecasts by type from 2019-2029 covering:
• Glass Pre-Filled Syringes
• Pen Injectors and Autoinjectors
• Plastic Pre-Filled Syringes
• Forecasts from 2019-2029 of the leading therapeutic sectors for the Pre-Filled Syringes market:
• Insulin Therapies
• Rheumatoid Arthritis (RA) Therapies
• Growth Hormones
• Vaccines
• PCSK9 Inhibitors
• Pre-Filled Syringes national market forecasts from 2019-2029, covering:
• United States
• Japan
• Germany
• France
• United Kingdom
• Italy
• Spain
• Brazil
• Russia
• India
• China
Each national market is further segmented by type and application.
• Forecasts from 2019-2029 of selected leading products:
• Enbrel
• Genotropin
• Humalog
• Humira
• Humulin
• Lantus
• Levemir
• Norditropin
• NovoMix
• NovoRapid/Novolog
• Praluent
• Repatha
• Rituxan
• Toujeo
• Trulicity
• Assessment of the leading pre-filled syringes manufacturers and related technology manufacturers.
• SWOT and STEP analysis of the global pre-filled syringes market.
Visiongain’s study is intended for anyone requiring commercial analyses for the Pre-Filled Syringes Market and leading companies. You find data, trends and predictions.
Buy our report today Global Pre-Filled Syringes Market Forecast 2019-2029: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors. Insulin Therapies. Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1. Global Pre-Filled Syringes Market Overview
1.2. Global Pre-Filled Syringes Market Segmentation
1.3. Why You Should Read This Report
1.4. How This Report Delivers
1.5. Key Questions Answered by This Analytical Report
1.6. Who is This Report For?
1.7. Methodology
1.8. Frequently Asked Questions (FAQ)
1.9. Associated Visiongain Reports
1.10. About Visiongain
2. Introduction to Pre-Filled Syringes
2.1. What are Pre-Filled Syringes?
2.2. A Brief History of Pre-Filled Syringes
2.3. Design and Manufacture of Pre-Filled Syringes
2.3.1. Glass and Plastic Syringes
2.3.2. Safety and the Pre-Filled Syringe Market
2.3.3. Concerns over Needlestick Injuries
2.4. An Introduction to Pen Injectors and Autoinjectors
2.4.1. Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
2.4.2. What Determines Injection Device Choice?
2.5. Glass versus Plastic
2.5.1. Glass
2.5.2. Plastic
2.6. Future Directions for Pre-Filled Syringes
2.7. Pre-Filled Syringes: Market Segmentation
2.8. Scope of this Report
2.8.1. Products Excluded from this Report
2.9. Currency Exchange Rates in This Report
3. Pre-Filled Syringes: World Market 2019-2029
3.1. Pre-Filled Syringes as a Share of the Global Drug Delivery Market
3.2. The World Pre-Filled Syringes Market in 2018
3.2.1. World Pre-Filled Syringes Market: Market Shares by Segment 2018
3.2.2. Leading Companies in the Pre-Filled Syringes Market
3.2.3. Market Genericisation and Pre-Filled Syringes
3.3. World Pre-Filled Syringes Market: Sales Forecast by Value, 2019-2029
3.4. How Will Segmental Market Shares Change to 2029?
3.5. World Pre-Filled Syringes Market: Drivers and Restraints 2018-2029
3.5.1. Innovation and Targeted New Molecules to Drive Market Growth
3.5.2. Human Factors and Regulatory Requirements
3.5.3. Advances in Pre-Filled Syringe Manufacturing
3.5.4. The Injectable Drug Pipeline is Substantial
3.5.5. Competing Drug Delivery Technologies
3.5.6. Complex Molecules Sensitivity and Packaging
3.5.7. Necessity of Improved Connected Devices Technology
3.6. World Pre-Filled Syringes Market: Future Trends 2018-2029
3.6.1. Automation and Inspection to meet high quality standards
3.6.2. Shift from Hospital Care to Home Care
3.7. Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
3.7.1. Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2018-2029
3.7.2. Glass Pre-Filled Syringes: Drivers and Restraints 2018-2029
3.8. Plastic Pre-Filled Syringes: Rapid Growth Forecasted
3.8.1. Plastic Pre-Filled Syringes Market: Sales Forecast by Revenue, 2018-2029
3.8.2. Plastic Pre-Filled Syringes: Drivers and Restraints 2018-2029
3.9. Pen Injectors and Autoinjectors: A Growing Segment
3.9.1. Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2018-2029
3.9.2. Pen Injectors and Autoinjectors: Drivers and Restraints 2018-2029
3.9.3. Insulin and Other Biologics to Lead Market Growth
4. Leading National and Regional Markets 2019-2029
4.1. National Breakdown of the World Pre-Filled Syringes Market
4.2. World Pre-Filled Syringes Market: National Markets Forecast 2019-2029
4.2.1. How Will National Market Shares Change to 2029?
4.3. Regional Breakdown of the World Pre-Filled Syringes Market
4.4. World Pre-Filled Syringes Market: Regional Markets Forecast 2019-2029
4.4.1. How Will Regional Market Shares Change to 2029?
4.5. US Pre-Filled Syringes Market Forecast 2018-2029
4.5.1. US Pre-Filled Syringes Market: Trends and Developments
4.5.1.1. New Drug and Device Launches to Drive Growth to 2029
4.5.1.2. The Budget Control Act 2011 and the Medical Excise Tax
4.6. Japanese Pre-Filled Syringes Market Forecast 2019-2029
4.7. EU5 Pre-Filled Syringes Market Forecast 2019-2029
4.8. Emerging Markets: Pre-Filled Syringes Market Forecast 2019-2029
4.8.1. Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
4.8.2. Chinese Pre-Filled Syringes Market Forecast 2019-2029
4.8.3. Indian Pre-Filled Syringes Market Forecast 2019-2029
4.8.4. Russian Pre-Filled Syringes Market Forecast 2019-2029
4.8.5. Brazilian Pre-Filled Syringes Market Forecast 2019-2029
5. Leading Therapeutic Sectors for Pre-Filled Syringes 2018-2029
5.1. Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2018
5.1.1. Vaccines and Heparins Are Major Market Sectors
5.1.2. Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
5.1.3. Growth for Key Market Sectors 2018-2029
5.2. Pre-Filled Syringes and Pen Injectors for Diabetes 2018-2029
5.2.1. Insulin Market Forecast 2018-2029
5.2.2. High Rates of Pen Injector Use in the EU and Japan
5.2.3. Insulin Pumps: A Technology to Challenge Pen Injectors to 2029?
5.2.4. MannKind’s Afrezza: Inhalable Insulin Approved in US
5.2.5. Injection Devices for Biosimilar Insulin Products
5.2.6. Roche’s Lucentis: First and Only FDA Approved Prefilled Syringe Treatment for Diabetic Retinopathy
5.2.7. FDA Approves Highest Capacity Insulin Pen
5.3. Rheumatoid Arthritis: Leading Biologics Dominate the Market
5.3.1. Rheumatoid Arthritis Market Forecast 2018-2029
5.3.2. All Major Injectable Therapies Are Marketed in Proprietary Devices
5.3.3. Novel Injection Systems for RA: Meeting the Needs of Patients
5.3.4. The Receding Threat from Oral Therapies to 2029
5.4. Growth Hormones: Outlook to 2029
5.4.1. Growth Hormones Market Forecast 2019-2029
5.4.2. Biosimilar Growth Hormones and Pen Injectors
5.4.3. Uptake of Needle-Free Injectors for Growth Hormones
5.5. The Vaccine Market Outlook 2019-2029
5.5.1. Vaccine Market Forecast 2019-2029
5.5.2. Single-Use Devices for Vaccine Delivery
5.5.2.1. BD Uniject: A Private-Public Collaboration
5.5.3. Needle-Free Injectors for Vaccines
5.5.4. Other Trends in Vaccine Delivery
5.6. PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
5.6.1. PCSK9 Inhibitors Market Forecast 2019-2029
5.6.2. PCSK9 Inhibitors and Pre-Filled Syringes/Injectors
5.7. Others: Launch of injectables for Anaphylaxis, MS, Cancer expected to drive the Market for Prefilled Syringes
6. Leading Pre-Filled Device Therapies 2019-2029
6.1. Leading Insulin Therapies Using Pen Injectors 2018-2029
6.1.1. Lantus: The World’s Best-Selling Insulin Analogue
6.1.1.1. SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
6.1.1.2. Lantus: Sales Forecast 2018-2029
6.1.2. NovoLog: The Leading Fast-Acting Insulin
6.1.2.1. NovoLog FlexPen: To Be Retired
6.1.2.2. Novo’s New FlexTouch Pen Launched
6.1.2.3. NovoLog: Sales Forecast 2018-2029
6.1.3. Humalog
6.1.3.1. Humalog: HumaPen and KwikPen
6.1.3.2. Humalog: Sales Forecast 2017-2027
6.1.4. Other Products in the Insulin Market
6.1.4.1. Levemir
6.1.4.2. Novomix
6.1.4.3. Humulin
6.1.4.4. Trulicity
6.1.4.5. Toujeo
6.2. Top Biologics for Rheumatoid Arthritis: Device Outlook to 2029
6.2.1. Humira: The Biggest-Selling Drug in 2017
6.2.1.1. The Humira Pen Is an Innovative Delivery Device
6.2.1.2. Humira: Sales Forecast 2017-2027
6.2.1.3. Humira: EU Price
6.2.2. Rituxan (Rituximab): The Second Leading RA Drug
6.2.3. Enbrel: The Leading Competitor to Humira
6.2.3.1. Pre-Filled Injection Devices Available for Enbrel
6.2.3.2. Enbrel: Sales Forecast 2019-2029
6.2.3.3. Other leading RA drugs and developments
6.2.3.3.1 Actemra/RoActemra (tocilizumab)
6.2.3.3.2 Kevzara (sarilumab)
6.3. Growth Hormones: Two Products Dominated the Market in 2018
6.3.1. Norditropin: The Leading Growth Hormone
6.3.1.1. Norditropin: Sales Forecast 2018-2029
6.3.2. Genotropin: Sales Forecast 2019-2029
6.4. Outlook for Leading PCSK9 Products 2017-2027
6.4.1. Praluent (alirocumab, Sanofi/Regeneron)
6.4.1.1. Praluent: Sales Forecast 2019-2029
6.4.1.2. Amgen Suit Against Sanofi/Regeneron’s Praluent
6.4.2. Repatha (evolocumab, Amgen)
6.4.2.1. Repatha: Sales Forecast 2019-2029
7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2018
7.1. Leading Pre-Filled Syringe Manufacturers market share in 2017
7.1.1. Becton, Dickinson & Company: The Market Leader
7.1.1.1. Becton, Dickinson & Company: Pre-Filled Syringes Product Portfolio
7.1.1.2. BD Historical Revenue and Market Prospects
7.1.1.3. Recent Acquisitions by BD
7.1.1.4. BD AutoShield Duo Pen Needle Launched in 2014
7.1.1.5. BD launched first syringe that offers new delivery solution for people with insulin resistance
7.1.1.6. BD launched Advanced Prefillable Syringe for Higher Volume Injection of Biologics
7.1.1.7. BD launched Ultra-Fine Micro Pen Needle
7.1.2. Gerresheimer
7.1.2.1. Gerresheimer: Pre-Filled Syringes Product Portfolio
7.1.2.2. Gerresheimer: Expansion of Product Manufacturing Facility
7.1.2.3. Gerresheimer: Products in Development
7.1.2.4. Patent Application for Gerresheimer’s Gx Baked-On RTF
7.1.2.5. Gerresheimer Commissioned to Manufacture Simponi Autoinjectors
7.1.2.6. Gerresheimer Opens First Development Center in China
7.1.3. Schott
7.1.3.1. Schott: Pre-Filled Syringes Product Portfolio
7.1.3.2. Schott Historical Revenue and Market Prospects
7.1.3.3. Schott: Expansion in India
7.2. Other Notable Pre-Filled Syringe Manufacturers
7.2.1. Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
7.2.2. Nipro: Leading Japanese Contract Manufacturer
7.2.2.1. Nipro’s 2012 Acquisition of MGlas
7.2.3. Stevanato Group/Ompi: Insulin Vials Market Leader
7.2.4. Weigao: Pre-Filled Syringes for China and Beyond
7.2.5. Unilife: Pre-Filled Safety Syringes
7.2.6. Roselabs: Entered the Market in 2012
7.2.7. Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
7.2.8. Other Companies
7.3. Leading Pen Injector and Autoinjector Manufacturers in 2015
7.3.1. SHL Group
7.3.1.1. SHL Group: Pen Injectors and Autoinjectors Product Portfolio
7.3.1.2. SHL Group Market Prospects
7.3.2. Ypsomed
7.3.2.1. Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
7.3.2.2. Ypsomed Historical Revenue and Market Prospects
7.3.2.3. Ypsomed: Recent Developments
7.3.3. Haselmeier
7.3.3.1. Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
7.3.3.2. Haselmeier: Market Prospects
7.3.4. Owen Mumford
7.3.4.1. Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
7.3.5. Bespak: Entering the Auto-Injectors Market
7.3.6. Other Leading and Emerging Autoinjector Manufacturers
7.4. Leading Pre-Filled Syringe Component Manufacturers in 2017
7.4.1. Datwyler
7.4.1.1. Datwyler Historical Revenue and Market Prospects
8. Qualitative Analysis of the Pre-Filled Syringes Market 2019-2029
8.1. SWOT Analysis of the Pre-Filled Syringes Market
8.2. Strengths
8.2.1. Pre-Filled Syringes and Pen/Autoinjectors are Used in Chronic Conditions
8.2.2. Device Manufacturers Offer a Range of Products
8.2.3. Customisation and Product Differentiation
8.2.4. Effective Lifecycle Management
8.2.5. Advantages associated with pre-filled syringes
8.3. Weaknesses
8.3.1. Patients with Needle Phobia
8.3.2. Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
8.3.3. Risk of Extractables and Leachables
8.3.4. Higher Cost and Greater Cold Chain and Storage Requirements
8.4. Opportunities
8.4.1. Biosimilars Represent a Growing Market
8.4.2. Viscous and Large-Volume Drugs Require Novel Devices
8.4.3. Technological Developments Expanding Product Portfolios
8.4.4. Many Injectable Drugs in the Pipeline
8.4.5. Growth in Emerging Markets
8.4.6. Rising demand for Disposables
8.5. Threats
8.5.1. Alternative Technologies: Needle-Free and Bolus Injectors
8.5.2. New Oral Therapies for Many Chronic Conditions
8.5.3. Increasing Regulatory Barriers
8.5.4. Cost Pressures on Healthcare Payers
8.6. STEP Analysis of the Pre-Filled Syringes Market
8.6.1. Social Factors: Rising Disease Incidence and Demand for At-Home Care
8.6.2. Technological Developments: Improved Safety and Administration
8.6.3. Economic Pressures: Pre-Filled Syringes Are Cost Efficient
8.6.3.1. High Barriers to Market Entry Exist
8.6.4. Political Issues: Regulatory Developments for Pre-Filled Syringes
8.7. Regulatory and Safety Outlook for Pre-Filled Syringes, 2019-2029
8.7.1. Needlestick Safety and Prevention
8.7.2. International Regulations for Needlestick Prevention
8.7.2.1. The US: The First Country to Introduce Needlestick Legislation
8.7.2.2. The EU: New Rules from 2013 Onwards
8.7.2.3. Needlestick Safety in Japan
8.7.2.4. Legislation for Needlestick Safety in Emerging Markets
8.7.3. Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
8.7.3.1. Ancillary versus Integrated Safety Devices
8.7.4. Extractables and Leachables
8.7.4.1. Companies Will Reduce Sources of Extractables and Leachables
8.7.4.2. Products that Minimise Extractables and Leachables
8.7.4.3. Protein Aggregation: The Challenge of Biological Drugs
8.7.4.4. Regulatory Requirements for Extractables and Leachables
8.8. Biologics and the Pre-Filled Syringes Market, 2019-2029
8.8.1. Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
8.8.2. Biologics Provide New Challenges for Device Manufacturers
8.8.2.1. Lyophilised Drugs and Dual-Chamber Devices
8.8.3. Delivery Opportunities for High Viscosity Drugs
8.8.4. Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
8.9. The Role of Patients in Pre-Filled Syringe Industry Development and Growth
8.9.1. Chronic Disease Incidence
8.9.2. The Rise in At-Home Care
8.9.3. Improving Patient Adherence
8.9.4. Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
8.10. Technological Developments in Pre-Filled Syringes to 2029
8.10.1. Product Differentiation Will be Vital in Crowded Treatment Markets
8.10.2. Product Customisation: Adapting Injection Devices
8.10.3. Trends in Manufacturing Materials for Pre-Filled Syringes
8.10.4. Competing Technologies Will Challenge Pre-Filled Syringes
8.10.4.1. Will Needle-Free Devices Become a Significant Competing Technology?
8.10.4.2. Patients Prefer Oral Drug Delivery
8.11. Outsourcing in the Pre-Filled Syringe Industry
8.11.1. Contract Medical Device Manufacturing
8.11.2. Contract Filling of Pre-Filled Syringes
9. Conclusions
9.1. Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
9.2. The World Pre-Filled Syringes Market in 2018
9.2.1. Current Leading Pre-Filled Syringes Segments
9.2.2. Leading Pre-Filled Syringes Companies
9.2.3. Leading National and Regional Markets
9.3. World Pre-Filled Syringes Market Forecast 2019-2029
9.4. The Future of the Pre-Filled Syringes Market?
9.4.1. Glass Syringes Will Continue to Dominate
9.4.2. Innovation for Growth
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 3.1 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Segment, 2018-2029
Table 3.2 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Revenue, 2018, 2023 and 2029
Table 3.3 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 3.4 Selected Proprietary Polymers for Plastic Pre-Filled Syringes, 2018
Table 3.5 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 3.6 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.1 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by National Market, 2018
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2018-2029
Table 4.3 Market Shares (%) of Leading National Pre-Filled Syringes Markets, 2018, 2023 and 2029
Table 4.4 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by Regional Market, 2018
Table 4.5 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Regional Market, 2018-2029
Table 4.6 Market Shares of Leading Regional Pre-Filled Syringes Markets, 2018, 2023 and 2029
Table 4.7 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.8 U.S. Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.9 U.S. Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.10 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.11 Japanese Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.12 Japanese Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.13 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2018-2029
Table 4.14 UK Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.15 UK Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.16 Germany Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.17 Germany Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.18 France Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.19 France Pre-Filled Syringes Market Forecast, By Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.20 Italy Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.21 Italy Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.22 Spain Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.23 Spain Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.24 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.25 Chinese Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.26 Chinese Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.27 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.28 Indian Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.29 Indian Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.30 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.31 Russian Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.32 Russian Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.33 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.34 Brazilian Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 4.35 Brazilian Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.1 Pen Manufacturing Agreements for Leading Insulin Brand Manufacturers, 2017
Table 5.2 Selected Biosimilar Insulin Pen Injectors, 2017
Table 5.3 Insulin Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.4 Prefilled Syringes Application in Diabetes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.5 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.6 Prefilled Syringes Application in Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.7 Growth Hormone Therapies in Pen Injectors, 2018
Table 5.8 Growth Hormones Market Forecast: Revenues ($m), AGR and CAGR, 2018-2029
Table 5.9 Selected Biosimilar Growth Hormones in Emerging Markets, 2018
Table 5.10 Vaccines Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.11 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 5.12 Prefilled Syringes Application in Anaphylaxis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.1 Leading Pre-Filled Insulin Therapies: Revenues ($m), 2015-2018
Table 6.2 Sanofi: Lantus Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.3 Novo Nordisk: NovoLog Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.4 Eli Lilly: Humalog Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.5 Novo Nordisk: Levemir Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.6 Novo Nordisk: NovoMix Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.7 Eli Lilly: Humulin Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.8 Eli Lilly: Trulicity Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.9 Sanofi: Toujeo Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.10 Leading Pre-Filled Rheumatoid Arthritis Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.11 AbbVie/Eisai: Humira Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.12 Genentech/Biogen Idec: Rituxan Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.13 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.14 Leading Pre-Filled Growth Hormone Therapies: Revenues ($m), AGR (%) and CAGR (%), 2014-2018
Table 6.15 Novo Nordisk: Norditropin Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.16 Pfizer: Genotropin Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.17 Sanofi: Praluent Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 6.18 Amgen: Repatha Revenue ($m), AGR (%) and CAGR (%), 2018-2029
Table 7.1 BD: Overview, 2017
Table 7.2 BD: Pre-Filled Injection Systems, 2017
Table 7.3 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2012-2017
Table 7.4 Gerresheimer: Overview, 2017
Table 7.5 Gerresheimer: Pre-Filled Injection Systems, 2017
Table 7.6 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m) 2015-2017, AGR (%)
Table 7.7 Schott: Overview, 2017
Table 7.8 Schott: Pre-Filled Injection Systems, 2017
Table 7.9 Schott: Net Revenue ($m), AGR (%) and CAGR (%), 2012-2017
Table 7.10 Unilife: Pre-Filled Syringe Product Portfolio, 2017
Table 7.11 Unilife: Net Revenue ($m), AGR (%) and CAGR (%), 2010-2016
Table 7.12 SHL Group: Overview, 2017
Table 7.13 SHL Group: Pen Injector and Autoinjector Portfolio, 2017
Table 7.14 Ypsomed: Overview, 2017
Table 7.15 Ypsomed: Pen Injector and Autoinjector Portfolio, 2017
Table 7.16 Ypsomed: Delivery Devices Revenue ($m), AGR (%) and CAGR (%), 2012-2017
Table 7.17 Haselmeier: Overview, 2017
Table 7.18 Haselmeier: Pen Injector and Autoinjector Portfolio, 2017
Table 7.19 Owen Mumford: Overview, 2017
Table 7.20 Owen Mumford: Pen Injector and Autoinjector Portfolio, 2017
Table 7.21 Datwyler: Overview, 2017
Table 7.22 Datwyler: Pharma Packaging Revenue ($m), AGR (%) and CAGR (%), 2012-2017
Table 8.1 Benefits and Weaknesses to Pre-Filled Syringes as an Injectable Delivery Device, 2018
Table 8.2 Pre-Filled Syringes Market: STEP Analysis, 2019-2029
Table 8.3 Selected Safety Products for Pre-Filled Syringes, 2018
Table 8.4 Selected Pre-Filled Injection Devices for Lyophilised Drugs, 2018
Table 8.5 Pre-Filled Syringe Manufacturers: Alternative Injectable Technologies, 2018
Table 8.6 Selected Insulin Pumps Available, 2018
Table 8.7 Oral Drug Competitors for Leading Pre-Filled Syringe Therapeutic Sectors, 2018-2029
Table 8.8 Selected Leading CMOs: Pre-Filled Syringe Filling Capabilities, 2018
List of Figures
Figure 1.1 Global Pre-Filled Syringes Market Segmentation Overview, 2017
Figure 2.1 Diagram of Syringe Parts
Figure 2.2 Timeline of Pre-Filled Syringe Development
Figure 2.3 Major Trends for Pre-Filled Syringe Market Growth, 2017
Figure 3.1 World Pre-Filled Syringes Market: Market Shares (%) by Segment, 2018
Figure 3.2 World Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 3.3 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2018
Figure 3.4 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2023
Figure 3.5 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2029
Figure 3.6 World Pre-Filled Syringes Market: Drivers and Restraints, 2018-2029
Figure 3.7 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), 2018-2029
Figure 3.8 Glass Pre-Filled Syringes Market: Drivers and Restraints, 2018-2029
Figure 3.9 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), 2018-2029
Figure 3.10 Plastic Pre-Filled Syringes Market: Drivers and Restraints, 2018-2029
Figure 3.11 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 3.12 Pen Injectors and Autoinjectors Market: Drivers and Restraints, 2018-2029
Figure 4.1 World Pre-Filled Syringes Market: Revenues ($m) by National Market, 2018
Figure 4.2 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2018
Figure 4.3 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2023
Figure 4.4 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2029
Figure 4.5 World Pre-Filled Syringes Market: Revenues ($m) by Regional Market, 2018
Figure 4.6 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2018
Figure 4.7 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2023
Figure 4.8 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2029
Figure 4.9 U.S. Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 4.10 U.S. Pre-Filled Syringes Market Forecast by Type: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Figure 4.11 U.S. Pre-Filled Syringes Market Forecast by Application: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Figure 4.12 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 4.13 Japanese Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
Figure 4.14 Japanese Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
Figure 4.15 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m) by National Market, 2018-2029
Figure 4.16 UK Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
Figure 4.17 UK Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
Figure 4.18 Germany Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
Figure 4.19 Germany Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
Figure 4.20 France Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
Figure 4.21 France Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
Figure 4.22 Italy Pre-Filled Syringes Market Forecast by Type: Revenues ($m), 2018-2029
Figure 4.23 Italy Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
Figure 4.24 Spain Pre-Filled Syringes Market Forecast by Type: Revenues ($m, 2018-2029
Figure 4.25 Spain Pre-Filled Syringes Market Forecast by Application: Revenues ($m), 2018-2029
Figure 4.26 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 4.27 Chinese Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
Figure 4.28 Chinese Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
Figure 4.29 Indian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 4.30 Indian Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
Figure 4.31 Indian Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
Figure 4.32 Russian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 4.33 Russian Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
Figure 4.34 Russian Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
Figure 4.35 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 4.36 Brazilian Pre-Filled Syringes Market Forecast by Type: Revenues ($m) and AGR (%), 2018-2029
Figure 4.37 Brazilian Pre-Filled Syringes Market Forecast by Application: Revenues ($m) and AGR (%), 2018-2029
Figure 5.1 Insulin Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 5.2 Prefilled Syringes Application in Diabetes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Figure 5.3 Rheumatoid Arthritis Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 5.4 Prefilled Syringes Application in Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Figure 5.5 Growth Hormones Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 5.6 Vaccines Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 5.7 PCSK9 Inhibitors Market Forecast: Revenues ($m) and AGR (%), 2018-2029
Figure 5.8 Prefilled Syringes Application in Anaphylaxis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2029
Figure 6.1 Sanofi: Lantus Revenue ($m) and AGR (%), 2018-2029
Figure 6.2 Novo Nordisk: NovoLog Revenue ($m) and AGR (%), 2018-2029
Figure 6.3 Eli Lilly: Humalog Revenue ($m) and AGR (%), 2018-2029
Figure 6.4 Novo Nordisk: Levemir Revenue ($m) and AGR (%), 2018-2029
Figure 6.5 Novo Nordisk: NovoMix Revenue ($m) and AGR (%), 2018-2029
Figure 6.6 Eli Lilly: Humulin Revenue ($m) and AGR (%), 2018-2029
Figure 6.7 Eli Lilly: Trulicity Revenue ($m) and AGR (%), 2018-2029
Figure 6.8 Sanofi: Toujeo Revenue ($m) and AGR (%), 2018-2029
Figure 6.9 AbbVie/Eisai: Humira Revenue ($m) and AGR (%), 2018-2029
Figure 6.10 Genentech/Biogen Idec: Rituxan Revenue ($m) and AGR (%), 2018-2029
Figure 6.11 Amgen/Pfizer: Enbrel Revenue ($m) and AGR (%), 2018-2029
Figure 6.12 Novo Nordisk: Norditropin Revenue ($m) and AGR (%), 2018-2029
Figure 6.13 Pfizer: Genotropin Revenue ($m) and AGR (%), 2018-2029
Figure 6.14 Sanofi/Regeneron: Praluent Revenue ($m) and AGR (%), 2018-2029
Figure 6.15 Amgen: Repatha Revenue ($m) and AGR (%), 2018-2029
Figure 7.1 Global Pre-filled syringes market market share in 2017
Figure 7.2 BD: Pharmaceutical Systems Revenue ($m), AGR (%), 2012-2017
Figure 7.3 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m) 2015-2017, AGR (%)
Figure 7.4 Schott: Net Revenue ($m) and AGR (%), 2012-2017
Figure 7.5 Unilife: Net Revenue ($m) and AGR (%), 2010-2016
Figure 7.6 Ypsomed: Delivery Devices Revenue ($m) and AGR (%), 2012-2017
Figure 7.7 Datwyler: Pharma Packaging Revenue ($m) and AGR (%), 2012-2017
Figure 8.1 Pre-Filled Syringes Market: Strengths and Weaknesses, 2019-2029
Figure 8.2 Pre-Filled Syringes Market: Opportunities and Threats, 2017-2027
Figure 9.1 World Pre-Filled Syringes Market Forecast: Revenues ($m) by Segment, 2018-2029
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
